Zobrazeno 1 - 10
of 40
pro vyhledávání: '"G. A. Nerodo"'
Autor:
T. A. Zykova, G. A. Nerodo, O. A. Bogomolova, M. N. Duritskiy, V. A. Sustretov, V. P. Nikitina, A. P. Menshenina, A. N. Shevchenko, I. A. Khomutenko, P. A. Kruze, E. V. Philatova
Publikováno v:
Медицинский вестник Юга России, Vol 9, Iss 1, Pp 42-50 (2018)
Objective: analysis of the type-specific prevalence of high-risk HPV in dependence on gender, age, the presence of cancer. Material and methods: 424 patients of the RRIO were examined. Urogenital smears in women and in men, urine in men were tested f
Externí odkaz:
https://doaj.org/article/bf0b08c4e6c748f188b59e6f9fdce918
Publikováno v:
Креативная хирургия и онкология, Vol 0, Iss 3, Pp 61-66 (2017)
Incidence of vulvar cancer in reproductive patients and peculiarities of clinical course of the disease have been studied. 839 vulvar cancer patients aged 20-90 years have been treated at Gynecology Department of Rostov Research Oncologic Institute w
Externí odkaz:
https://doaj.org/article/505ca1d8be0d406fa8f3a29c20b53333
Autor:
G. A. Nerodo, E. M. Frantsiyants, O. E. Kravtsova, V. P. Nikitina, E. V. Verenikina, I. S. Nikitin, N. V. Chernikova
Publikováno v:
Кубанский научный медицинский вестник, Iss 3, Pp 96-102 (2016)
Ovarian cancer is still among the most actual unsolved problems in oncogynecological practice. We studied the effect of neoadjuvant polychemotherapy on parameters of free radical processes in tissues of tumorous and contralateral (non-tumorous) ovari
Externí odkaz:
https://doaj.org/article/394b11aaa68a4259b8af65e026f70686
Autor:
I. A. Goroshinskaya, G. A. Nerodo, E. I. Surikova, P. S. Surikova, V. V. Vnukov, E. V. Shalashnaja, I. V. Neskubina, L. A. Nemashkalova, N. A. Maximova, M. M. Sergeeva
Publikováno v:
Сибирский онкологический журнал, Vol 0, Iss 4, Pp 45-49 (2016)
The state of antioxidant system (the activity of catalase and ceruloplasmine), the intensity of chemiluminescence, and oxidative modification of proteins were studied in blood plasma of 61 patients with ovarian cancer (cystadenocarcinoma) III–IV st
Externí odkaz:
https://doaj.org/article/7cca4d8f9a8842ffa07b237a36173a34
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1-2, Pp 98-102 (2014)
Thirty two with the ascitic form of Stages IIIC—IV ovarian cancer underwent 1 to 3 courses of intraperitoneal multidrug therapy using a protein ascitic fluid concentrate (PAFC) as a solvent of drugs (cisplatin, cyclophosphan, doxorubicin) according
Externí odkaz:
https://doaj.org/article/00ca13f9373e4afb96f3479271f68ccc
Autor:
M. B. Kozlova, E. M. Frantziyantz, G. A. Nerodo, R. N. Salatov, R. G. Luganskaya, I. P. Sidorenko, M. V. Kashubina
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1-2, Pp 29-33 (2014)
The hormonal background was studied in 32 menopausal patients who had primary breast cancer (Stage III) or its recurrence in the postoperative scar. The patients with the primary process, unlike those with a recurrence, were found to have increased a
Externí odkaz:
https://doaj.org/article/1ba812dcc41e42aca9e102fe13370335
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1, Pp 113-116 (2014)
Fixation of the preserved ovaries to uterine round ligament allow to retain ovarian function, not only during postoperative radiotherapy of stage Ib cervical cancer due to their transposition, but also after completing pelvic radiation because of pre
Externí odkaz:
https://doaj.org/article/651c2f1636894f8a8941120af3d0f83e
Publikováno v:
Опухоли женской репродуктивной системы, Vol 0, Iss 1, Pp 44-46 (2014)
A parallel study of some parameters of the endocrine and immune systems was conducted in 120 patients with vulvar cancer prior to treatment.Most patients were found to have impaired immunogenesis: the reduced count and function of T and B lymphocytes
Externí odkaz:
https://doaj.org/article/4fecd7351d094d4397fc93d2579fcbe9
Autor:
E. V. Shalashnaja, G. A. Nerodo, A. P Men’shenina, L. A. Nemashkalova, I. A. Goroshinskaja, V. F.P Nikitina, I. V Neskubina, N. D Ushakova
Publikováno v:
Russian Journal of Oncology. 22:25-31
Introduction. The application of efferent therapy (extracorporeal therapy) now becomes relevant due to the individual intolerance to various drugs, side effects of a great many of drugs, which is especially important when treating onco-gynecological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bbab0ff5ed869b24a47e639e86b1171
https://doi.org/10.18821/1028-9984-2017-22-1-25-31
https://doi.org/10.18821/1028-9984-2017-22-1-25-31
Autor:
E. I. Surikova, I. A. Goroshinskaja, G. A. Nerodo, E. M. Frantsiyants, M. L. Malejko, E. V. Shalashnaja, P. S. Kachesova, L. A. Nemashkalova, A. V. Leonova
Publikováno v:
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 10:335-340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5a270ba7f3241b99170533ceac5ae19
https://doi.org/10.1134/s1990750816040089
https://doi.org/10.1134/s1990750816040089